---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-006979"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2023-03-08T23:59:59+00:00"
generated_at: "2026-06-18T08:14:05.473249+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oragenics appoints Janet Huffman as CFO effective March 7, 2023

## Summary
- Janet Huffman named CFO, Secretary and Treasurer; base salary $250,000, target bonus 35%.
- Granted 7,000 stock options at $4.00 exercise price under 2021 Equity Incentive Plan.
- Options vest in five equal tranches over two years; severance includes 6 months salary if terminated without cause.
- Huffman previously CFO of TRxADE HEALTH and Arboreta Healthcare; brings public company finance and M&A experience.

## SEC filing metadata
- accession: 0001493152-23-006979
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2023-03-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315223006979/0001493152-23-006979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315223006979/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-006979
- JSON: https://secwatch.observer/filing/0001493152-23-006979.json
- Plain text: https://secwatch.observer/filing/0001493152-23-006979.txt

## Key facts
- Executive change
  Janet Huffman was appointed as Chief Financial Officer at ORAGENICS INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: announced that the Board of Directors approved the appointment of Janet Huffman, as the Company’s new Chief Financial Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315223006979/0001493152-23-006979-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.